CD276 and cancer: On the basis of all these facts, there is an intriguing hypothesis that rather than on immune cells, there may be a receptor for B7‐H3 on cancer cells, which is of genuine novelty and importance for cancer cell proliferation and stemness through the binding of this potential receptor and B7‐H3.